Meridian Clinical Research logo in white.

Anthrax Vaccine Study

 Study Now Open in Omaha, NE

Anthrax is an infectious disease caused by the spore-forming bacterium B anthracis. Though it is rare in the U.S. and is not contagious, people exposed to infected livestock or animal products can get sick with anthrax. Anthrax could also be used as a weaponized biological agent. Anthrax is designated as a Tier 1 agent because it presents a significant potential for deliberate misuse.

In this study, Meridian is investigating the safety of a vaccine — there will be no exposure to anthrax (an infectious disease caused by the spore-forming bacterium B anthracis).

Eligible participants…

  • Must be age 18 to 45
  • May receive compensation for time and travel
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.

Study Location

Meridian Clinical Research
3319 N 107th St
Omaha, NE 68134

Submit Your Information

Meridian Clinical Research logo in white.

About Meridian Clinical Research

Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.

Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.